Ronaldo’s excitement grips Old Trafford as star completes medical ahead of United return

By , K24 Digital
On Tue, 31 Aug, 2021 11:10 | < 1 min read
Manchester United bound Cristiano Ronaldo applauds fans during a past league fixture: PHOTO/COURTESY

Cristiano Ronaldo has completed his Manchester United medical as he closes on a return to his former club ahead of a home fixture against Newcastle United at the Old Trafford.

United announced they had reached an agreement with Juventus to re-sign the 36-year-old forward on Friday.

Personal terms have been agreed on a two-year contract, with the required aspects of the deal to be finalised before the deadline on Tuesday night.

The Premier League club will pay around €15m (£12.87m) plus a further €8m (£6.86m) in add-ons for the Portugal captain, who underwent a medical in Lisbon over the weekend.

Ronaldo scored 118 goals in 292 games during his first spell with United between 2003 and 2009.

Ronaldo’s departure from Juventus was confirmed on Friday by boss Massimiliano Allegri, who revealed he was told by the player he had “no intention” of representing the club again.

United’s rivals Manchester City were offered the chance to sign the 36-year-old and considered making a move, but the Premier League champions pulled out of negotiations.

Despite the fanfare of Ronaldo returning to bolster Solskjaer’s squad, question marks remain over the midfield.

Paul Pogba dropped back into midfield against Wolves, but his partnership with Fred does not look like a long-term solution, argues Adam Bate.

United’s recapture of the five-time Ballon d’Or winner has yet to be rubber-stamped, but the anticipation in the red half of Manchester is palpable ahead of the Portugal international returning to his English footballing home.

The football league takes a break amid international games, with World cup games lined up this weekend.

Are you a Kenyan in the diaspora with a story to tell? Do you know someone of Kenyan origin doing something remarkable in the diaspora? Do you have an opinion that you would like to share? Email us at [email protected]